-
Something wrong with this record ?
Topic application of meloxicam-loaded polymeric nanocapsules as a technological alternative for treatment of the atopic dermatitis in mice
Douglas Mroginski Weber, Guilherme Teixeira Voss, Renata Leivas de Oliveira, Caren A.R. da Fonseca, Jaini Paltian, K. C. Rodriguez, Francine Rodrigues Ianiski, R. A. Vaucher, Cristiane Luchese, Ethel Antunes Wilhelm
Language English Country Czech Republic
Document type Research Support, Non-U.S. Gov't
- MeSH
- Administration, Cutaneous MeSH
- Dermatitis, Atopic * drug therapy MeSH
- Dosage Forms MeSH
- Meloxicam administration & dosage MeSH
- Disease Models, Animal MeSH
- Mice, Inbred BALB C MeSH
- Nanocapsules MeSH
- Drug Carriers MeSH
- Treatment Outcome MeSH
- Drug Administration Routes MeSH
- Animals MeSH
- Check Tag
- Female MeSH
- Animals MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
This study investigated the effect of the topical treatment with meloxicam-loaded nanocapsules (M-NC) on symptoms, inflammatory response and oxidative parameters in an atopic dermatitis (AD) model in BALB/c mice. 2,4-Dinitrochlorobenzene (DNCB) was applied to the dorsal skin on days 1–3 for sensitization. Mice were challenged with DNCB on the ear (on days 14–29) and dorsal skin (on days 14, 17, 20, 23, 26, and 29). Treatments with blank nanocapsules (B-NC), free meloxicam (M-F) or M-NC were applied to the backs of the mice from days 14 to 29. On the day 30, skin severity scores and scratching behaviour were determined. After that, ears and dorsal skin were removed for determination of inflammatory parameters (edema and myeloperoxidase (MPO) activity) and oxidative parameters (thiobarbituric acid reactive species (TBARS) and non-protein thiol (NPSH) levels), respectively. DNCB increased the severity of skin lesions, scratching behaviour, edema and MPO activity of ears and dorsal skin TBARS levels. M-NC reversed skin severity scores, scratching behaviour and inflammatory response induced by DNCB. B-NC and M-F did not have effect in this model. In summary, meloxicam carried by polymeric nanocapsules reversed inflammatory response and ameliorated symptoms in an AD model.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18039896
- 003
- CZ-PrNML
- 005
- 20190322163503.0
- 007
- ta
- 008
- 181210s2018 xr ad f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jab.2018.03.003 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Weber, Douglas Mroginski $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 245 10
- $a Topic application of meloxicam-loaded polymeric nanocapsules as a technological alternative for treatment of the atopic dermatitis in mice / $c Douglas Mroginski Weber, Guilherme Teixeira Voss, Renata Leivas de Oliveira, Caren A.R. da Fonseca, Jaini Paltian, K. C. Rodriguez, Francine Rodrigues Ianiski, R. A. Vaucher, Cristiane Luchese, Ethel Antunes Wilhelm
- 504 __
- $a Literatura
- 520 9_
- $a This study investigated the effect of the topical treatment with meloxicam-loaded nanocapsules (M-NC) on symptoms, inflammatory response and oxidative parameters in an atopic dermatitis (AD) model in BALB/c mice. 2,4-Dinitrochlorobenzene (DNCB) was applied to the dorsal skin on days 1–3 for sensitization. Mice were challenged with DNCB on the ear (on days 14–29) and dorsal skin (on days 14, 17, 20, 23, 26, and 29). Treatments with blank nanocapsules (B-NC), free meloxicam (M-F) or M-NC were applied to the backs of the mice from days 14 to 29. On the day 30, skin severity scores and scratching behaviour were determined. After that, ears and dorsal skin were removed for determination of inflammatory parameters (edema and myeloperoxidase (MPO) activity) and oxidative parameters (thiobarbituric acid reactive species (TBARS) and non-protein thiol (NPSH) levels), respectively. DNCB increased the severity of skin lesions, scratching behaviour, edema and MPO activity of ears and dorsal skin TBARS levels. M-NC reversed skin severity scores, scratching behaviour and inflammatory response induced by DNCB. B-NC and M-F did not have effect in this model. In summary, meloxicam carried by polymeric nanocapsules reversed inflammatory response and ameliorated symptoms in an AD model.
- 650 12
- $a atopická dermatitida $x farmakoterapie $7 D003876
- 650 _2
- $a meloxikam $x aplikace a dávkování $7 D000077239
- 650 _2
- $a způsoby aplikace léků $7 D004333
- 650 _2
- $a aplikace kožní $7 D000279
- 650 _2
- $a lékové formy $7 D004304
- 650 _2
- $a nanokapsle $7 D053769
- 650 _2
- $a nosiče léků $7 D004337
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a myši inbrední BALB C $7 D008807
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Voss, Guilherme Teixeira $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Oliveira, Renata Leivas de $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Fonseca, Caren A.R. da $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Paltian, Jaini $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Rodriguez, K. C. $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Ianiski, Francine Rodrigues $u Centro Universitário Franciscano, CEP, Nanosciences Postgraduate Program, Santa Maria, Brazil
- 700 1_
- $a Vaucher, R. A. $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Luchese, Cristiane $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 700 1_
- $a Wilhelm, Ethel Antunes $u Universidade Federal de Pelotas (UFPel), Centre for Chemical, Pharmaceutical and Food Sciences (CCQFA), Centre of Scientific Chemistry, Biochemistry and Bioprospecting Postgraduate Program (PPGBBio), Pelotas, Brazil
- 773 0_
- $t Journal of applied biomedicine $x 1214-021X $g Roč. 16, č. 4 (2018), s. 337-343 $w MED00012667
- 856 41
- $u https://jab.zsf.jcu.cz/pdfs/jab/2018/04/11.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y 4 $z 0
- 990 __
- $a 20181210075422 $b ABA008
- 991 __
- $a 20190322163832 $b ABA008
- 999 __
- $a ok $b bmc $g 1357784 $s 1036958
- BAS __
- $a 3
- BMC __
- $a 2018 $b 16 $c 4 $d 337-343 $i 1214-021X $m Journal of Applied Biomedicine $x MED00012667
- LZP __
- $c NLK125 $d 20190322 $a NLK 2018-52/vt
